Odonate Therapeutics, Inc. (NASDAQ:ODT) Long Term Shareholder Notice: Investigation of Potential Wrongdoing

San Diego, CA -- (SBWIRE) -- 01/13/2021 -- Certain directors of Odonate Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.